Finance

Beta
Lists
2496:HKG
Wuhan YZY Biopharma Co Ltd
HK$4.30
+2.38%
(+0.10) 1D
May 28, 3:13:54 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2496...
Mkt. cap
814.17M
Avg. vol.
500.00
Volume
0.00
52-wk high
HK$8.40
52-wk low
HK$3.90
EPS
-HK$0.51
Shares outstanding
179.48M
No. of employees
106
Mkt. cap
814.17M
Avg. vol.
500.00
Volume
0.00
52-wk high
HK$8.40
52-wk low
HK$3.90
EPS
-HK$0.51
Shares outstanding
179.48M
No. of employees
106
News stories
From sources across the web
About Wuhan YZY Biopharma Co Ltd
CEO-
Employees106
Founded2010
Headquarters-
SectorBiotechnology
Websiteyzybio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
22.18M
22.18M
11.24M
11.24M
Cost of goods sold
14.76M
14.76M
13.30M
13.30M
Cost of revenue
14.76M
14.76M
13.30M
13.30M
Research and development expenses
30.09M
30.09M
9.01M
9.01M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.04M
6.04M
5.36M
5.36M
Operating expense
36.14M
36.14M
9.51M
9.51M
Total operating expenses
50.90M
50.90M
22.81M
22.81M
Operating income
-28.71M
-28.71M
-11.57M
-11.57M
Other non operating income
-
-
-15.50K
-15.50K
EBT including unusual items
-29.42M
-29.42M
-12.95M
-12.95M
EBT excluding unusual items
-29.41M
-29.41M
-12.95M
-12.95M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-4.85M
-4.85M
Net income
-29.42M
-29.42M
-12.95M
-12.95M
Net profit margin
-132.60%
-132.60%
-115.16%
-115.16%
Earnings per share
-
-
-
-
Interest and investment income
251.00K
251.00K
128.50K
128.50K
Interest expense
-1.19M
-1.19M
-1.28M
-1.28M
Net interest expenses
-941.00K
-941.00K
-1.16M
-1.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.67M
-27.67M
-10.71M
-10.71M
Gain or loss from assets sale
-
-
7.50K
7.50K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more